Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Hetronifly“
Suchtreffer
Begriffe & Kennungen
Hetronifly · 4.8 · Immune-mediated uveitis
Eintrag öffnenHetronifly · 4.8 · Infusion-related reactions
Eintrag öffnenHetronifly · 4.8 · Infusion-related reactions occurred in 1.7% of patients, including Grade 3 in 0.1% of patients and Grade 4 in
Eintrag öffnenHetronifly · 4.8 · Laboratory abnormalities
Eintrag öffnenHetronifly · 4.8 · Nervous system: immune-mediated encephalitis, neuropathy peripheral, epilepsy, encephalopathy, peripheral sens
Eintrag öffnenHetronifly · 4.8 · No overall differences in safety were reported between elderly (≥ 65 years) and younger patients. Data for pat
Eintrag öffnenHetronifly · 4.8 · Other clinically significant immune-mediated adverse reactions reported in patients who received serplulimab w
Eintrag öffnenHetronifly · 4.8 · Other immune-mediated adverse reactions
Eintrag öffnenHetronifly · 4.8 · Other: panic disorder, abnormal behaviour, cholangitis acute, sepsis, peritonitis, blood alkaline phosphatase
Eintrag öffnenHetronifly · 4.8 · Pituitary disorders Pituitary disorders occurred in 0.8% of patients, including Grade 3 in 0.1% of patients. T
Eintrag öffnenHetronifly · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenHetronifly · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenHetronifly · 4.8 · Respiratory, thoracic and mediastinal: dyspnoea, chronic obstructive pulmonary disease, respiratory failure.
Eintrag öffnenHetronifly · 4.8 · Serplulimab in combination with chemotherapy Infections and infestations Very common pneumonia a Common urinar
Eintrag öffnenHetronifly · 4.8 · Serplulimab is associated with immune-mediated adverse reactions. The data for the following immune-mediated a
Eintrag öffnenHetronifly · 4.8 · Serplulimab was discontinued due to adverse reactions in 8.1% of patients. The most common adverse reactions l
Eintrag öffnenHetronifly · 4.8 · Summary of the safety profile
Eintrag öffnenHetronifly · 4.8 · Table 2. Adverse reactions in patients treated with serplulimab*
Eintrag öffnenHetronifly · 4.8 · The most common Grade ≥ 3 adverse reactions were neutropenia (46.2%), leukopenia (27.3%), anaemia (25.8%), thr
Eintrag öffnenHetronifly · 4.8 · The most common immune-mediated adverse reactions were hypothyroidism (11.5%), immune- mediated skin reactions
Eintrag öffnen